Mesodermal lineage |
|
|
|
|
Vascular smooth muscle cells |
DMEM +1% FBS, 5 ng/ml TGF-β1, 2.5 ng/ml BMP4 |
7 days |
The expression of α-SMA, Calponin, SM22α, MHC |
(Wang et al., 2010) |
Vascular smooth muscle cells |
LG-DMEM + 1% FBS, 5 ng/ml TGF-β1, and 2.5 ng/ml BMP4 |
7 days |
The expression of α-SMA, Calponin, SM22α, MHC |
(Aji et al., 2016) |
Vascular endothelial cell |
EGM-2 + 2% FBS, 50 ng/ml rhVEGF, 100 ng/ml BMP4, under hypoxia (2% O2) |
|
CD31, VEGF-R2, and VE-cadherin |
(Shang et al., 2019) |
Cardiomyocytes |
DMEM +10% FBS, 10 ng/ml bFGF, 20 ng/ml BMP4 |
4 days |
The expression of GATA4, MEF2C, MLC2A, MLC2V, a-Actinin, Troponin I |
(Hasani et al., 2020) |
Vascular smooth muscle cell |
DMEM +1% FBS, 5 ng/ml TGF-β 2.5 ng/ml BMP4 |
7 days |
The expression of α-SMA, SM22α, calponin and SM-MHC |
(Lin et al., 2020) |
Vascular smooth muscle cells |
DMEM +1% FBS, 5 ng/ml TGF-β 2.5 ng/ml BMP4 |
4 days |
The expression of -SMA, Caldesmon, SM22α, MHC |
Yogi et al. (2021)
|
Ectodermal lineage |
|
|
|
|
Keratinocyte |
DMEM +0.5 nM (17 ng/ml) BMP-4, 0.3 mM ascorbic acid 2-phosphate, 0.5 ug/ml hydrocortisone, 5 nM (1.5 ng/ml) retinoic acid, 20 ng/ml EGF |
7 days |
The expression of pan-cytokeratin, CK1, CK14, CK18, Involucrin |
(Petry et al., 2018) |
Keratinocytes |
DMEM +1 μM All-trans retinoic acid, 25 ng/ml BMP4, co-culture with human dermal fibroblasts (NHDFs) (5 × 104 cells/ml) keratinocyte serum-free medium (KSFM) + co-culture with NHDFs |
4 days |
Cytokeratin 10 (K10), Type VII collagen (Col7) |
(Maeda et al., 2017) |
7 days |